Skip to main content
Caplight Logo









NeoCura Bio-Medical Technology Co., Ltd.

NeoCura Bio-Medical Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.neocura.com.cn/

Last Round

Series A

Extension

Dec 21, 2021

Total Funding Raised

$116.65M

Company Overview

NeoCura Bio-Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A Extension round in December 2021.

NeoCura Bio-Medical Technology Co., Ltd. is a biotechnology company that develops an artificial intelligence-driven RNA technology platform for the research and development of innovative tumor vaccines and immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NeoCura Bio-Medical Technology Co., Ltd. Comparables

Compare NeoCura Bio-Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

NeoCura Bio-Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Likang Life Sciences
85%
Arcturus Therapeutics Holdings Inc.
83%
Evaxion A/S
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NeoCura Bio-Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 21, 2021
Series ADec 24, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

NeoCura Bio-Medical Technology Co., Ltd. Investors

Notable investors and investment history

NeoCura Bio-Medical Technology Co., Ltd. investors
InvestorRounds
Alwin CapitalSeries A
IDG CapitalSeries A
PICC Capital Insurance Asset ManagementSeries A Extension
Kunlun CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Added Lastoria, a medical devices startup, as a customer.

  • Dec 21, 2021

    $78M round led by PICC Capital and Zhou Yahui.

Book a demo to see all signals

For institutional investors. Book with your work email.

NeoCura Bio-Medical Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

NeoCura Bio-Medical Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NeoCura Bio-Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Is NeoCura Bio-Medical Technology Co., Ltd. a public or private company?

NeoCura Bio-Medical Technology Co., Ltd. is a private company.

What is the current stock price of NeoCura Bio-Medical Technology Co., Ltd.?

NeoCura Bio-Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks NeoCura Bio-Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NeoCura Bio-Medical Technology Co., Ltd. worth (valuation)?

Valuation information for NeoCura Bio-Medical Technology Co., Ltd. is not publicly available.

Can I buy NeoCura Bio-Medical Technology Co., Ltd. stock?

NeoCura Bio-Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NeoCura Bio-Medical Technology Co., Ltd.'s last funding round?

NeoCura Bio-Medical Technology Co., Ltd.'s most recent funding round was Series A Extension on December 21, 2021.

Who are the main investors in NeoCura Bio-Medical Technology Co., Ltd.?

Key investors in NeoCura Bio-Medical Technology Co., Ltd. include PICC Capital Insurance Asset Management, Kunlun Capital.

Will NeoCura Bio-Medical Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for NeoCura Bio-Medical Technology Co., Ltd..

How can I track NeoCura Bio-Medical Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in NeoCura Bio-Medical Technology Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range8
Year Founded2017
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?